Feline immunodeficiency virus (FIV), discovered in 1986, is the causat
ive agent of feline immunodeficiency syndrome (FAIDS) in domestic cats
. Our understanding of FIV immunopathogenesis has expanded in recent y
ears, but the development of an effective vaccine has been slow. This
review briefly summarizes the current status of FIV infection and FIV
vaccine research, including successes and failures of vaccine trials a
nd the potential mechanisms of vaccine protection. Overall, the result
s from the vaccine trials indicate that vaccine protection against exp
erimental FIV infection is achievable and lends optimism to the prospe
ct of developing an effective FIV vaccine for veterinary use.